Mutators can drive the evolution of multi-resistance to antibiotics
Open Access
- 13 June 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 19 (6) , e1010791
Abstract
Antibiotic combination therapies are an approach used to counter the evolution of resistance; their purported benefit is they can stop the successive emergence of independent resistance mutations in the same genome. Here, we show that bacterial populations with ‘mutators’, organisms with defects in DNA repair, readily evolve resistance to combination antibiotic treatment when there is a delay in reaching inhibitory concentrations of antibiotic—under conditions where purely wild-type populations cannot. In populations of Escherichia coli subjected to combination treatment, we detected a diverse array of acquired mutations, including multiple alleles in the canonical targets of resistance for the two drugs, as well as mutations in multi-drug efflux pumps and genes involved in DNA replication and repair. Unexpectedly, mutators not only allowed multi-resistance to evolve under combination treatment where it was favoured, but also under single-drug treatments. Using simulations, we show that the increase in mutation rate of the two canonical resistance targets is sufficient to permit multi-resistance evolution in both single-drug and combination treatments. Under both conditions, the mutator allele swept to fixation through hitch-hiking with single-drug resistance, enabling subsequent resistance mutations to emerge. Ultimately, our results suggest that mutators may hinder the utility of combination therapy when mutators are present. Additionally, by raising the rates of genetic mutation, selection for multi-resistance may have the unwanted side-effect of increasing the potential to evolve resistance to future antibiotic treatments.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/M020975/1)
- Biotechnology and Biological Sciences Research Council (BB/M011208/1)
- UKRI Innovation/Rutherford Fund Fellowship (MR/R024936/1)
- Academy of Medical Sciences (SBF007\100096)
- Postdoctoral Seed Award from Earth and Environmental Sciences, The University of Manchester
- Wellcome Trust (204796/Z/16/Z)
- Swedish Research Council (Grant No. 638-2013-9243)
- The Maria de Maeztu program for Units of Excellence in R&D (MDM-2017-0711)
This publication has 129 references indexed in Scilit:
- Evolutionary rescue from extinction is contingent on a lower rate of environmental changeNature, 2013
- Rate and molecular spectrum of spontaneous mutations in the bacteriumEscherichia colias determined by whole-genome sequencingProceedings of the National Academy of Sciences, 2012
- EcoCyc: a comprehensive database of Escherichia coli biologyNucleic Acids Research, 2010
- Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced MutagenesisMolecular Cell, 2010
- Pharmacokinetics and Pharmacodynamics of Antibacterial AgentsInfectious Disease Clinics of North America, 2009
- Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyProceedings of the National Academy of Sciences, 2009
- Drug interactions modulate the potential for evolution of resistanceProceedings of the National Academy of Sciences, 2008
- Accelerated evolution of resistance in multidrug environmentsProceedings of the National Academy of Sciences, 2008
- Coevolution with viruses drives the evolution of bacterial mutation ratesNature, 2007
- Natural Selection and the Concept of a Protein SpaceNature, 1970